Study of Temporomandibular Joint Dysfunction
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DIJON · Oct 4, 2017
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Patients:
- • Patients who have provided verbal consent,
- • Patients over 18 years old,
- • Patients with mandible dentition compatible with placement of the kinetic measurement device,
- • Patients with a TMJ disease requiring surgery (irreducible dislocation of the joint disc, damage to the joint disc requiring discectomy, ankylosis or severe arthritis of the mandible requiring mandible implants or a TMJ prosthesis).
- Asymptomatic subjects:
- • Subjects who have provided verbal consent,
- • Subjects over 18 years old,
- • Subjects with Class 1 occlusion,
- • Subjects without dental implants,
- • Subjects with no history of joint dysfunction,
- • Absence of clicking, popping, or grating sounds during large movements and during palpation of the TMJ with the mouth slightly open (distance between incisors around 1 cm)
- • Absence of headache,
- • Absence of tinnitus,
- • Kinematic curves around the mean.
- Exclusion Criteria:
- • Adults under guardianship,
- • Patients without national health insurance cover.
About Centre Hospitalier Universitaire Dijon
The Centre Hospitalier Universitaire Dijon (CHU Dijon) is a leading academic medical institution in France, dedicated to advancing healthcare through innovative research and clinical trials. With a focus on patient-centered care, CHU Dijon integrates comprehensive medical services with cutting-edge research initiatives across various specialties. The institution is committed to enhancing clinical outcomes and improving health standards by facilitating rigorous scientific investigations and collaborations with national and international partners. By prioritizing ethical practices and adherence to regulatory standards, CHU Dijon aims to contribute significantly to the development of new therapies and medical technologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dijon, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials